ArticleBMC cancer2016
MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.
Margaret E Whicker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papertrialcites it
ArticleBMC cancer2016
Margaret E Whicker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.